Canaccord raised the firm’s price target on Hims & Hers to $38 from $28 and keeps a Buy rating on the shares. The stock rallied 70% in ...

Panaji: Health minister Vishwajit Rane on Monday said that the super-speciality block (SSB) at Goa Medical College at Bambolim will implement the hosp.

The Washington Post: This Year, Be Thankful For AI In Medicine Artificial intelligence is revolutionizing medicine, making health care more accurate and less expensive for everyone. (11/27) ...

On Friday, Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $32.15 which represents a slight increase of $1.81 or 5.97% from the prior close of $30.34. The stock opened at ...

Everyone has a right to their own opinions. But we must ensure the antisemitic views of individuals are known to their ...

The small cap stocks had a good November with the Russell 2000 index this week hitting a new 52-week peak — higher than the ...

On Wednesday, Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.34 which represents a decrease of $-0.34 or -1.11% from the prior close of $30.68. The stock opened at $31.49 and ...

Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key ...

The bitter irony is that Republican policies in states with high obesity rates only exacerbate the gaps in health outcomes.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

Hims & Hers (HIMS) is up 14.0%, or $4.29 to $34.97.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium ...

(Goldman, 11/27) Bloomberg: Hims & Hers Shares Rally As FDA Pick Marty Makary Seen As Major Ally Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the ...